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Identification of genetic loci shared 
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Olav B. Smeland  1, Yunpeng Wang1,2, Min-Tzu Lo3, Wen Li1, Oleksandr Frei1, Aree Witoelar1, 
Martin Tesli1,4, David A. Hinds5, Joyce Y. Tung5, Srdjan Djurovic6,7, Chi-Hua Chen3, Anders M. 
Dale2,3,8 & Ole A. Andreassen  1
Schizophrenia is associated with differences in personality traits, and recent studies suggest that 
personality traits and schizophrenia share a genetic basis. Here we aimed to identify specific genetic 
loci shared between schizophrenia and the Big Five personality traits using a Bayesian statistical 
framework. Using summary statistics from genome-wide association studies (GWAS) on personality 
traits in the 23andMe cohort (n = 59,225) and schizophrenia in the Psychiatric Genomics Consortium 
cohort (n = 82,315), we evaluated overlap in common genetic variants. The Big Five personality traits 
neuroticism, extraversion, openness, agreeableness and conscientiousness were measured using a 
web implementation of the Big Five Inventory. Applying the conditional false discovery rate approach, 
we increased discovery of genetic loci and identified two loci shared between neuroticism and 
schizophrenia and six loci shared between openness and schizophrenia. The study provides new insights 
into the relationship between personality traits and schizophrenia by highlighting genetic loci involved 
in their common genetic etiology.
Research on the construct and variation of human personality has revealed that personality and psychopathol-
ogy are related1–3. This is not only the case for personality disorders but also other mental disorders such as 
schizophrenia4. However, the mechanisms underlying this relationship remain elusive. Although personality and 
schizophrenia may relate to each other in several ways, such as influencing the expression of one another, or pre-
disposing for the development of one another, an intriguing question remains whether variation in personality 
and schizophrenia in fact share causative factors1–3. Both personality traits and schizophrenia are influenced 
by genetic factors with moderate to high heritability estimates (~0.45 and 0.6–0.86, respectively). Genome-wide 
association studies (GWAS) have revealed that the genetic architecture of personality traits and schizophrenia are 
composed by a number of common genetic variants with small effects7–11. Recently, we10 and others12 reported 
significant genetic correlations between several personality traits and schizophrenia10, 12. These findings indicate 
that personality traits and schizophrenia exist on a continuum in genomic space, and that some genetic variants 
associated with personality traits also affect susceptibility to schizophrenia10, 12. In order to increase the under-
standing of the specific molecular genetic mechanisms jointly influencing personality traits and schizophrenia, 
and inform the underlying biology linking these normal and pathological mental phenotypes, we here aimed to 
identify genetic loci shared between schizophrenia and personality traits.
The most influential personality model to emerge is the five-factor model, in which personality is defined by 
the five broad traits (the Big Five) neuroticism, extraversion, openness, agreeableness and conscientiousness13, 14. 
Through questionnaires, individuals are placed on continua of all five traits, which intend to account for 
basic behavioral tendencies that are universally present and stable throughout life15. Studies on personality in 
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schizophrenia consistently find increased neuroticism, decreased extraversion and decreased conscientiousness 
compared to normative levels or healthy controls16–24, and these differences appear to persist through active and 
residual phases of the illness16, 24. Moreover, longitudinal studies report that apparently healthy individuals with 
high neuroticism and low extraversion were more likely to be diagnosed with schizophrenia later on25, 26, indicat-
ing that differences in personality might precede the onset of schizophrenia.
Despite the assembly of very large GWAS cohorts (over tens of thousands of participants) much of the genetic 
architecture underlying susceptibility to schizophrenia and personality traits remains to be defined, and their 
biological underpinnings are still largely unknown. To date, GWAS have identified hundreds of single nucleotide 
polymorphisms (SNPs) for schizophrenia11, while fewer SNPs are identified for personality traits7–10. Recently, we 
conducted a GWAS on the Big Five personality traits in the 23andMe cohort and identified six replicable variants 
associated with personality traits10. We also quantified genetic correlations between schizophrenia and person-
ality traits using linkage disequilibrium (LD) score regression and compared personality trait GWAS data from 
23andMe (n = 59,225) with GWAS data on schizophrenia from the Psychiatric Genomics Consortium (PGC; 
n = 17,115). We found that schizophrenia was significantly correlated with openness and conscientiousness, but 
not with the other personality traits10. However, another study reported a significant genetic correlation between 
neuroticism and schizophrenia using GWAS data on neuroticism in the UK Biobank sample (n = 106,716) and 
GWAS data on schizophrenia in the larger PGC cohort (n = 79,845)12. It is important to note that while correla-
tions estimated by LD Score regression indicate the degree of shared genetic influences between two traits at the 
genome-wide level, they are agnostic about the individual variants jointly influencing these phenotypes.
The genome-wide significant SNPs identified by GWAS only explain a minor fraction of the estimated herita-
bility7–9, 11. However, in aggregate, common SNPs explain a substantial portion of the variance of schizophrenia27 
and personality traits10, indicating the presence of many variants with associations too weak to be detected using 
standard GWAS statistical analysis. To extract more of the “hidden heritability” within existing GWAS, we have 
developed Bayesian statistical tools that leverage the polygenetic overlap between complex traits28–30. Specifically, 
we condition the false discovery rate (FDR) for discovery of SNPs in a primary trait on overlapping associations 
in a secondary trait28–30. Using this methodology, we have successfully increased discovery of genetic risk loci and 
identified shared loci between schizophrenia and associated phenotypes including bipolar disorder31, cardiovas-
cular disease risk factors32, and multiple sclerosis33. Here, we applied the same statistical approach and analyzed 
GWAS on the Big Five personality traits and schizophrenia to identify shared genetic loci.
Methods
Ethics Statement. All GWASs investigated in the current study were approved by the local ethic commit-
tees and informed consent was obtained from all participants10, 11. Further, the Regional Committees for Medical 
Research Ethics - South East Norway have evaluated the current protocol and found that no additional institu-
tional review board approval was needed, because no individual data was used. All methods were performed in 
accordance with the relevant guidelines and regulations.
Participant Samples. We obtained GWAS results in the form of summary statistic (p-values and z-scores). 
Data on personality traits were acquired from the 23andMe cohort (n = 59,225)10 and data on schizophrenia from 
the Psychiatric Genomics Consortium (PGC) 2 study (n = 82,315)11. Details of the inclusion criteria, genotyping 
and phenotype characteristics are described in the in the original publications10, 11. We corrected all p-values for 
inflation using a recently developed genomic inflation control procedure31, 32, 34, 35.
Statistical Analyses. Visualizing enrichment. To visualize overlap in SNP associations, we constructed 
conditional Q-Q plots where we display the distribution of p-values for the primary phenotype conditional on 
significance levels in a secondary phenotype. Associations in the primary phenotype (schizophrenia or person-
ality trait) were conditioned on a p-value threshold in the secondary phenotype (personality trait or schizophre-
nia), i.e. p < 0.1, p < 0.01 and p < 0.001. If statistical enrichment of the primary phenotype exists, there should be 
successive leftward deflections as levels of association with the secondary phenotype increase28, 31–34. The enrich-
ment seen can be directly interpreted in terms of true discovery rate (TDR = 1 − FDR)36 (See Supplementary 
Material for details). We also constructed fold-enrichment plots, which are equivalent to conditional Q-Q plots, 
but provide a more direct visualization of polygenic enrichment. To assess for polygenic effects below the stand-
ard GWAS significance threshold, we focused the conditional Q-Q plots and fold-enrichment plots on SNPs 
with nominal log10(p) < 7.3 (corresponding to p > 5 × 10−8) and after random pruning, where one random SNP 
per LD block (defined by an r2 > 0.1) was used11, 12, 37. As with other methods evaluating genetic overlap using 
GWAS data, including LD score regression38 and stratified FDR39, complex correlations among the test-statistics 
may bias the estimate of the conditional FDR. The extended major histocompatibility complex (MHC)11 (loca-
tion 25652429–33368333) and chromosomal region 8p23.1 (location 7242715–12483982) are two regions with 
well-known complicated LD structures40. Therefore we also constructed conditional Q-Q plots after excluding 
SNPs within these regions. Furthermore, to be conservative, we removed SNPs outside the MHC or 8p23.1 in LD 
(r2 > 0.1) with any SNP in these regions.
Detection of shared genetic loci using conjunction FDR. To detect shared genetic loci we used a genetic epide-
miology framework based on the conjunction FDR28. The standard FDR framework derives from a model that 
assumes that the distribution of test statistics in a GWAS can be formulated as a mixture of null and non-null 
effects, with true associations (non-null effects) having more extreme test statistics than false associations (null 
effects). The FDR can be interpreted as the probability that a SNP is null given that its p-value is as small as or 
smaller than its observed p-value. Conjunction FDR, denoted by FDRtrait1&trait2 is defined as the posterior proba-
bility that a SNP is null for either phenotype or both simultaneously, given that its p-values for both traits are as 
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small as or smaller than the observed p-values31, 32, 34. We obtained a conservative estimate of conjunction FDR 
via the conditional FDR. The conditional FDR, denoted by FDRtrait1|trait2, is defined as the posterior probability 
that a given SNP is null for the first trait given that the p-values for both traits are as small or smaller than the 
observed p-values31–34. A conservative estimate of FDRtrait1&trait2 is given by the maximum between FDRtrait1|trait2 
and FDRtrait2|trait141. Hence, the conjunction FDR is the maximum of the conditional FDR for schizophrenia given 
a personality trait and vice versa, and SNPs that exceed a stringent conjunction FDR threshold are highly probable 
to be non-null in both schizophrenia and the personality trait simultaneously. While the conditional FDR can be 
used to reorder SNPs based on the additional information provided by the associated secondary traits, the con-
junction FDR pinpoints shared loci, since a low conjunction FDR is only possible if there is an association with 
the two traits of interest jointly. We used an overall FDR threshold of 0.05. Given that the conjunction FDR is a 
genome-wide approach, it is possible that inclusion of larger LD blocks can impact the model fit and confound 
the results. Therefore we computed the model after random pruning and excluding SNPs within the MHC and 
8p23.1, two genomic regions that show intricate LD and are associated with schizophrenia11 and neuroticism10, 12, 
respectively.
To visualize the location of the shared genetic variants associated with personality traits and schizophrenia, 
we constructed a ‘Conjunction FDR Manhattan plot’, showing all SNPs with a significant conjunction FDR within 
an LD block in relation to their chromosomal location. The strongest signal was identified after ranking all SNPs 
based on the conjunction FDR and removing SNPs in LD r2 > 0.1 with any higher ranked SNP. On the basis of 
1KGP LD structure, significant loci identified by conjunction FDR < 0.05 were clustered into LD blocks at the 
LD – r2 > 0.1 level. These blocks are numbered (locus #) in Table 1. Any block may contain more than one SNP. 
Genes close to each locus were obtained from the NCBI gene database. We investigated the direction of allelic 
effects in the conjunctional loci by comparing the schizophrenia z-scores against the personality trait z-scores. In 
the Supplementary information we present ‘Conditional FDR Manhattan plots’ for schizophrenia, neuroticism 
and openness showing all SNPs with a significant conditional FDR within an LD block in relation to their chro-
mosomal location. The strongest signal was identified after ranking all SNPs based on the conditional FDR and 
removing SNPs in LD r2 > 0.1 with any higher ranked SNP.
Stratified replication rate using schizophrenia substudies. We assessed whether pleiotropic enriched 
schizophrenia-SNPs replicate at a higher rate using the 52 schizophrenia GWAS sub-studies11. Sub-studies were 
randomly partitioned 500 times. For each random partition, half of the sub-studies were randomly assigned to 
the “discovery” sample and the complement to the “replication” sample. The combined discovery z-score and 
combined replication z-score of each SNP were calculated, and the average rate of replication (p < 0.05) was 
assessed across 1,000 equally spaced bins spanning the range of –log10(p-values) observed in the discovery sam-
ples. Cumulative replication rates were calculated independently for each of the three pleiotropic enrichment 
categories, as well as for all SNPs. For details, see Supplementary methods.
Results
Enrichment of schizophrenia SNPs due to association with personality traits, and vice 
versa. We observed enrichment of associations with schizophrenia across different levels of association with 

















1 rs11582132 (intergenic) BRINP2 1q25.2 A/C 4.23E-02 −3.53 −3.74 4.08E-04 1.85E-04
2 rs6429422 (intronic) SDCCAG8 1q43 T/G 3.58E-02 4.15 3.79 3.36E-05 1.54E-04
3 rs940404 (intronic) LRRC16A 6p22.2 T/A 4.23E-02 NaN NaN 1.61E-09 2.07E-04
4 rs3130564 (intronic) PSORS1C1 6p21.33 C/T 3.58E-02 4.24 3.77 2.25E-05 1.60E-04
5 rs7779548 (3′-UTR variant) DGKI 7q33 G/A 4.97E-02 4.42 3.64 9.66E-06 2.75E-04
7 rs9951150 (intergenic) AK093940 18q21.2 A/G 3.58E-02 −3.76 −3.79 1.69E-04 1.49E-04
SCZ and Neuroticism
6 rs2945232 (non coding transcript exon variant) FLJ10661 8p23.1 T/C 1.48E-03 −4.46 5.47 8.01E-06 4.44E-08
6 rs2048656 (intergenic) TNKS 8p23.1 G/A 5.80E-03 −4.19 5.01 2.84E-05 5.52E-07
8 rs11090039 (intronic) EP300 22q13.2 G/A 1.18E-03 −4.49 −4.95 7.00E-06 7.46E-07
Table 1. Shared gene variants (conjFDR < 0.05) between SCZ and personality traits. Independent complex 
or single gene loci (r2 < 0.1) with SNP(s) with a conjunction FDR (conjFDR) < 0.05 shared between SCZ and 
the Big Five personality traits. All significant SNPs are listed and sorted in each LD block and independent 
loci are listed consecutively (Locus #). All data were first corrected for genomic inflation. We also included 
agreeableness and conscientiousness in the conjFDR analysis, but there was no locus with conjFDR <0.05 
shared between either of these traits and SCZ. Abbreviations: Chr = chromosome, A1 = allele number 
one, A2 = allele number two, NaN = not a number; z-score not computable due to T-A polymorphism, 
SCZ = schizophrenia, FDR = false discovery rate.
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these personality traits (Fig. 1). In contrast, we found no evidence for enrichment in schizophrenia conditional 
on conscientiousness. We also constructed the reverse conditional Q-Q plots for personality traits conditional on 
different levels of association with schizophrenia, demonstrating consistent polygenic enrichment in four traits, 
neuroticism, agreeableness, openness and extraversion, but not conscientiousness (Supplementary Figure 1). 
The fold-enrichment plots emphasize the polygenic enrichment in schizophrenia as a function of neuroticism, 
agreeableness, openness and extraversion, but not conscientiousness (Fig. 2). For progressively stringent p-value 
thresholds for schizophrenia SNPs [i.e., increasing values of nominal −log10(p)], we found approximately 10-fold 
enrichment using neuroticism, 20-fold enrichment using extraversion, 20-fold enrichment using openness, and 
10-fold enrichment using agreeableness. In the reverse fold-enrichment plots displaying personality traits con-
ditional on different levels of significance in schizophrenia, we found approximately 175-fold enrichment for 
neuroticism, 100-fold enrichment for extraversion, 10-fold enrichment for openness, and 8-fold enrichment for 
agreeableness, but no detectable enrichment for conscientiousness (Supplementary Figure 2). The MHC has been 
shown to be one of the key driving factors for enrichment of genetic association in schizophrenia33. Thus, we 
repeated the stratified Q-Q plots and fold-enrichment plots after removing all SNPs located in the MHC. As 
shown by the Q-Q plots and fold-enrichment plots given in Supplementary Figures 3 and 4, SNPs located within 
the MHC region and other SNPs in LD (r2 > 0.1) with such SNPs had a minor effect on enrichment. Given the 
strong association of chromosomal region 8p23.1 with neuroticism10, 12, and intricate LD in this region, we con-
structed conditional Q-Q plots excluding SNPs located within 8p23.1 and other SNPs in LD (r2 > 0.1) with such 
SNPs. The figures demonstrate that the genetic overlap between schizophrenia and neuroticism largely depends 
on associations in this region (Supplementary Figure 5).
Susceptibility loci shared between schizophrenia and personality traits. Based on conjunction 
FDR < 0.05, we identified six loci shared between openness and schizophrenia annotated to genes BRINP2 
(rs11582132, intergenic variant), SDCCAG8 (rs6429422, intronic), LRRC16A (rs940404, intronic), PSORS1C1 
(rs3130564, intronic), DGKI (3′-UTR variant), and AK093940 (rs9951150, intergenic) (Table 1). PSORS1C1 maps 
onto the MHC region. Due to the intricate LD in this region, we consider this conjunctional hit as to reflect the 
involvement of MHC in both schizophrenia and openness rather than PSORS1C1 specifically. Further, we iden-
tified three loci shared between neuroticism and schizophrenia, which were annotated to FLJ10661 (rs2945232; 
non-coding transcript exon variant), TNKS (rs2048656; intergenic) and EP300 (rs11090039; intronic) (Table 1). 
FLJ10661 and TNKS map onto chromosomal band 8p23.1, a region spanning ~4 Mb with extended LD contain-
ing at least 36 genes10. Consequently, we consider these hits as to reflect the involvement of 8p23.1 in schizophre-
nia and neuroticism rather than these specific variants.
To visualize the shared loci, we constructed a conjunction FDR Manhattan plot (Fig. 3). All SNPs without 
pruning are shown, and the strongest signal in each LD block is encircled in black. The enlarged data points rep-
resent the significant SNPs (FDRtrait1&trait2 < 0.05), whereas the small points represent the non-significant SNPs. 
Figure 1. Conditional Q-Q plots of nominal versus empirical −log10 p-values (corrected for inflation) in 
schizophrenia (SCZ) below the standard GWAS threshold of p < 5 × 10−8 as a function of significance of 
association with agreeableness, openness, extraversion, neuroticism and conscientiousness at the level of −
log10(p) ≥ 1, −log10(p) ≥ 2, −log10(p) ≥ 3 corresponding to p ≤ 0.1, p ≤ 0.01, p ≤ 0.001, respectively. Blue line 
indicates all SNPs. Dotted line indicates the null hypothesis.
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We also constructed conditional FDR Manhattan plots for neuroticism given schizophrenia, openness given 
schizophrenia, and schizophrenia given neuroticism and openness, to visualize conditional loci (Supplementary 
Figures 6–8, respectively). Next, we evaluated the directionality of allelic effects in the conjunctional loci com-
paring z-scores in schizophrenia against z-scores in the personality trait (Table 1). For five loci shared between 
openness and schizophrenia (BRINP2, SDCCAG8, PSORS1C1, DGKI and AK093940), the effect directions were 
Figure 2. Fold-enrichment plots of enrichment versus nominal −log10 p-values (corrected for inflation) 
in schizophrenia (SCZ) below the standard GWAS threshold of p < 5 × 10−8 as a function of significance of 
association with agreeableness, openness, extraversion, neuroticism and conscientiousness at the level of −
log10(p) ≥ 1, −log10(p) ≥ 2, −log10(p) ≥ 3 corresponding to p ≤ 0.1, p ≤ 0.01, p ≤ 0.001, respectively. Blue line 
indicates all SNPs.
Figure 3. ‘Conjunction FDR Manhattan plot’ of conjunction (FDR < 0.05) values for schizophrenia (SCZ) and 
agreeableness, openness, extraversion, neuroticism and conscientiousness. SNPs with conjunction FDR < 0.05 
(i.e., −log10 FDR > 1.3) are shown with enlarged data points. A black circle around the enlarged data points 
indicates the most significant SNP in each LD block and this SNP was annotated with the closest gene which is 
listed above the symbols in each locus. The figure shows the localization of the ‘conjunctional loci’, and further 
details are provided in Table 1.
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concordant. Due to a T-A polymorphism, z-scores were not computable for the locus at LRRC16A (rs940404). 
The 8p23.1 loci show inverse associations in neuroticism and schizophrenia, while the EP300 locus shows con-
cordant associations.
Replication rates in schizophrenia are increased by personality trait association. To address 
the possibility that the observed pattern of differential enrichment results from spurious (i.e., non-generalizable) 
associations, we also calculated the empirical replication rate across the independent substudies contributing 
to the schizophrenia GWAS meta-analysis11. Supplementary Figures 9 and 10 show the empirical cumulative 
replication rate plots as a function of nominal p-value, the same categories as for the conditional Q-Q and 
fold-enrichment plots in Figs 1 and 2. We show that replication rates in schizophrenia SNPs are increased by 
conditioning on increasing levels of association with openness and neuroticism although this is not evident for 
the category −log10(pneuroticism) ≥ 3). Consistent with the pattern observed for replication rates in schizophrenia 
substudies, we found that the effect sizes of SNPs in enriched categories (for example, −log10(popenness) ≥ 3) repli-
cated better than effect sizes of SNPs in less-enriched categories (for example, −log10(popenness) ≥ 1; Supplementary 
Figures 10 and 11). This indicates that the fidelity of replication effect sizes is closely related to the conditional 
TDR.
Discussion
In the present study, we analyzed GWAS data on schizophrenia and the Big Five personality traits using the 
conditional FDR approach to evaluate overlap in common genetic variants. By conditioning on overlapping SNP 
associations, we were able to identify six loci shared between openness and schizophrenia, and two loci shared 
between neuroticism and schizophrenia. To validate our approach, we show that schizophrenia SNPs replicate at 
a higher rate across independent schizophrenia sub-studies as a function of association with personality traits. 
Altogether, our study provides new insights into the genetic architecture of schizophrenia and personality traits 
by identifying genetic loci that link personality trait variation and susceptibility to schizophrenia. The findings 
comply with accumulating evidence from genetics and neuroscience suggesting that mental disorders are not 
discontinuous with normal variation in neurobiological and behavior dimensions42, 43.
Recently, we estimated a significant positive genetic correlation between schizophrenia and openness using 
LD score regression10. In line with this result, five of the loci here found to be shared between schizophrenia and 
openness showed the same direction of allelic effects in the phenotypes, while one locus showed ambiguous 
effect directions (rs940404; LRRC16A) (Table 1). To our knowledge, none of the loci shared between openness 
and schizophrenia are identified in prior genetic studies on personality, whereas all loci are implicated in schiz-
ophrenia11, 44, 45. Levels of openness, which captures intellectual curiosity, unconventional thinking, imagination 
and versatility13, 46, appear to not differ from normality among patients with schizophrenia16–24. Nevertheless, it 
is worth noting that both openness and schizophrenia are linked to heightened dopamine activity47, 48, and are 
positively correlated with measures of creativity49–52, which could relate to the positive correlation among genetic 
effects shared between schizophrenia and openness. To determine the actual neurobiological and behavioral 
implications of the identified genetic variants and their role in openness and schizophrenia further studies are 
needed.
Schizophrenia is associated with high levels of neuroticism16–24, which can be defined as the tendency to 
experience negative emotions such as anxiety, anger and depression in stressful situations46. While one recent 
study estimated a significant positive genetic correlation between schizophrenia and neuroticism12, an analysis 
of different GWAS data did not reveal a significant genetic correlation between these phenotypes10. Here, we 
supplement these findings by identifying two genetic loci shared between schizophrenia and neuroticism. The 
intronic locus within EP300 (rs11090039) shows the same direction of allelic effects in schizophrenia and neu-
roticism, while the effect directions were opposite at chromosomal region 8p23.1 (Table 1). Notably, the EP300 
locus was genome-wide significant in both the primary schizophrenia GWAS11 and the 23andMe GWAS on neu-
roticism10. No loci within 8p23.1 reached genome-wide significance in the schizophrenia GWAS11. However, the 
gene TNKS is twice implicated as a gene affected by de novo mutations in schizophrenia53, 54. Recently, two inde-
pendent GWAS on neuroticism reported the strongest signal of association within 8p23.1, clearly demonstrating 
the importance of this locus in neuroticism10, 12. The opposite effect directions in schizophrenia and neuroticism 
detected at 8p23.1 could be attributable to different haplotypes/gene alleles involved in the phenotypes in this 
region55, or indicate that the same haplotypes/gene alleles are involved in both schizophrenia and neuroticism 
but the underlying biological mechanisms are distinct55. Fine-mapping studies are required to pinpoint the caus-
ative variants in 8p23.1. Of interest, the distal 15 Mb of the 8p chromosomal region (including 8p23.1) has been 
implicated as a potential hub for neuropsychiatric disorders56. The region is subject to structural variants associ-
ated with schizophrenia and autism, and shows high linkage to schizophrenia, bipolar disorder, and neuroticism 
among other phenotypes (for review see ref. 56).
Despite the clinical association between schizophrenia and low levels of conscientiousness16–24, and a signif-
icant negative genetic correlation between schizophrenia and conscientiousness10, we did not identify any gene 
loci shared between these phenotypes using the conditional FDR. The discrepancy may result from the different 
SCZ GWAS data on schizophrenia analyzed in these studies. In the LD score regression analysis, data from a 
smaller schizophrenia GWAS cohort (n = 17,115)57 were analyzed10, while the present study analyzed GWAS data 
on schizophrenia in the recent and larger PGC2 cohort (n = 82,315)11. Another possibility is that the observed 
negative genetic correlation between conscientiousness and schizophrenia using LD score regression is driven 
by a number of loci with too small effects to be detected by the conditional FDR approach. Further, although 
schizophrenia is associated with decreased levels of extraversion16–24, we did not detect any significant loci shared 
between schizophrenia and extraversion in the present study. However, the pleiotropic enrichment demonstrated 
by the conditional Q-Q plots (Figure 1) indicates overlapping SNP associations between schizophrenia and 
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extraversion. These findings may suggest that the current GWAS sample sizes for extraversion are not sufficiently 
powered to detect any shared genetic variants with schizophrenia10.
The conditional FDR methodology has been useful to elucidate genetic overlap in several complex pheno-
types including neuropsychiatric disorders31, 33, cardiovascular disease traits32 and immune-related diseases34. The 
current findings in the Big Five personality traits demonstrate that it may also be applied to genetic research on 
personality. By combining the 23andMe personality sample with the independent PGC2 schizophrenia GWAS11, 
we identified significant overlapping signals in a total of eight independent loci. Apart from the loci within chro-
mosomal region 8p23.1, all conjunctional loci were identified by the schizophrenia GWAS11. However, in the 
23andMe cohort, only loci associated with neuroticism were identified10. This illustrates the increased power 
of our combined analytical approach. Although it is likely that the shared loci discovered here would have been 
identified if the sample sizes in original GWAS had been adequately large, we show how combining summary 
statistics from independent samples provides an asset for gene discovery without the extra cost and resources 
needed to obtain new samples. Another strength of our conditional FDR approach is that it enables detection of 
overlapping variants even when the direction of effect is inconsistent across loci.
In conclusion, we provide new insights into the genetic etiology underlying schizophrenia and personality 
traits by increasing discovery of genetic loci and identifying common genetic variants shared between schiz-
ophrenia and the Big Five personality traits openness and neuroticism. By highlighting genetic loci that tran-
scend boundaries between schizophrenia and personality dimensions, our study may align with novel conceptual 
approaches to psychiatric nosologies, in which mental disorders are considered continuous with normal varia-
tion in psychological and neural phenotypes42, 43. Further investigation is required to determine the biological 
implications of the identified genetic variants to elucidate how neurobiological processes are altered to influence 
personality and risk of schizophrenia.
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